STIMIT AG begins trial for noninvasive diaphragm stimulation device
STIMIT AG, a medical technology innovator, has launched patient enrollment for its pivotal clinical trial assessing a noninvasive diaphragm neurostimulation device. This device, the STIMIT Activator 1, aims to address a significant challenge in intensive care units—preserving diaphragm function in patients reliant on mechanical ventilation. The FDA Investigational Device Exemption (IDE) study, titled “STIMIT Activator […]